Research Article
Seroprevalence of Hepatitis C, Hepatitis B, Cytomegalovirus, and Human Immunodeficiency Viruses in Multitransfused Thalassemic Children in Upper Egypt
Table 3
Risk factors for HCV.
| | Risk factors | | HCV | value | | No () | Yes () |
| | Age/years | Mean (SD) | 7.69 (5.01) | 12.63 (4.96) | 0.04 | | Median (range) | 9 (1–19) | 14 (6.5–18) |
| | Gender | Females | 26 (42.62%) | 9 (25.00%) | 0.08 | | Males | 35 (57.38%) | 27 (75.00%) |
| | Duration of the disease/years | Mean (SD) | 7.75 (4.62) | 10.56 (5.48) | 0.02 |
| | Frequency of blood transfusion/months | Mean (SD) | 1.11 (0.48) | 1.04 (0.30) | 0.57 |
| | Splenectomy | No | 36 (59.02%) | 20 (55.56%) | 0.74 | | Yes | 25 (40.98%) | 16 (44.44%) |
| | Ferritin level (ng/dL) | Mean (SD) | 2416 (1283) | 3652 (2173) | 0.006 |
| | Alanine transaminase (ALT) (U/L) | Mean (SD) | 48 (7.4) | 65 (5.1) | 0.001 |
| | Aspartate aminotransferase (AST) (U/L) | Mean (SD) | 47 (9.44) | 61 (8.9) | 0.02 |
|
|
values were obtained by using Mann-Whitney test or Chi-square test.
|
